These results suggest that VEGF regulation of CFH and other complement inhibitors is a common mechanism in the retina and thus may have implications for the pathogenesis of other retinal diseases, e.g., diabetic retinopathy. This evidence concerns the gene VEGFA and Abnormal retinal morphology.